Citation: Rm. Hargrave et al., DEVELOPMENT OF DRUG-RESISTANCE IS REDUCED WITH IDARUBICIN RELATIVE TOOTHER ANTHRACYCLINES, Anti-cancer drugs, 6(3), 1995, pp. 432-437
Citation: Dc. Marks et al., EXPRESSION OF MULTIDRUG-RESISTANCE IN RESPONSE TO DIFFERENTIATION IN THE K562 HUMAN LEUKEMIA-CELL LINE, Biochemical pharmacology, 50(4), 1995, pp. 475-480
Citation: Ki. Cocker et al., COGNITIVE-BEHAVIOR THERAPY WITH ADVANCED BREAST-CANCER PATIENTS - A BRIEF REPORT OF A PILOT-STUDY, Psycho-oncology, 3(3), 1994, pp. 233-237
Citation: Gmi. Su et al., DEVELOPMENT OF EXTENDED MULTIDRUG-RESISTANCE IN HL-60 PROMYELOCYTIC LEUKEMIA-CELLS, British Journal of Haematology, 88(3), 1994, pp. 566-574
Citation: Dc. Marks et al., DIFFERENTIATION AND MULTIDRUG-RESISTANCE IN RESPONSE TO DRUG-TREATMENT IN THE K562-HUMAN LEUKEMIA-CELL LINE, British Journal of Haematology, 84(1), 1993, pp. 83-89